INT217658

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.30
First Reported 2004
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 4
Total Number 6
Disease Relevance 1.35
Pain Relevance 0.17

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (MSTN) growth (MSTN) extracellular region (MSTN)
cytoplasm (MSTN)
Anatomy Link Frequency
muscle 2
myocytes 1
fat 1
MSTN (Homo sapiens)
Pain Link Frequency Relevance Heat
imagery 66 91.68 High High
positron emission tomography 18 88.48 High High
Inflammation 36 63.12 Quite High
Spinal cord 9 5.00 Very Low Very Low Very Low
cytokine 9 5.00 Very Low Very Low Very Low
depression 7 5.00 Very Low Very Low Very Low
antidepressant 6 5.00 Very Low Very Low Very Low
Neurotransmitter 6 5.00 Very Low Very Low Very Low
qutenza 6 5.00 Very Low Very Low Very Low
Action potential 6 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Frailty 111 99.92 Very High Very High Very High
Disease 9 92.08 High High
Acquired Immune Deficiency Syndrome Or Hiv Infection 24 87.60 High High
Hypoglycemia 3 87.52 High High
Parkinson's Disease 9 68.68 Quite High
Appetite Loss 13 64.40 Quite High
INFLAMMATION 36 63.12 Quite High
Body Weight 24 49.68 Quite Low
Reprotox - General 1 4 45.88 Quite Low
Endometriosis (extended) 5 22.00 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Among the newer approaches evolving towards treatment of muscle wasting is inhibition of myostatin, which counteracts the myogenic regulatory factors which promote the differentiation and proliferation of myocytes.
Negative_regulation (inhibition) of myostatin in myocytes associated with frailty
1) Confidence 0.30 Published 2009 Journal Osteoporos Int Section Body Doc Link PMC2832869 Disease Relevance 0.38 Pain Relevance 0
These have had mixed results, and newer approaches, such as myostatin inhibition and selective androgen receptor modulators, are also in the early stages of investigation.
Negative_regulation (inhibition) of myostatin
2) Confidence 0.30 Published 2009 Journal Osteoporos Int Section Body Doc Link PMC2832869 Disease Relevance 0.21 Pain Relevance 0.17
While there is considerable work which has demonstrated that myostatin suppression may have therapeutic potential for combating muscle wasting, the effect of age on myostatin expression is still under active investigation.
Negative_regulation (suppression) of myostatin in muscle associated with frailty
3) Confidence 0.22 Published 2009 Journal Osteoporos Int Section Body Doc Link PMC2832869 Disease Relevance 0.17 Pain Relevance 0
In agriculture research, eliminating and/or inhibiting myostatin may serve as an effective way to optimize animal growth leading to larger, leaner, and a more profitable livestock yield.
Negative_regulation (inhibiting) of myostatin
4) Confidence 0.14 Published 2004 Journal J Int Soc Sports Nutr Section Body Doc Link PMC2129137 Disease Relevance 0.16 Pain Relevance 0
While these theoretical possibilities may have great promise, research on the role of myostatin inhibition on muscle growth and repair is in the very early stages – particularly in humans.
Negative_regulation (inhibition) of myostatin in muscle
5) Confidence 0.14 Published 2004 Journal J Int Soc Sports Nutr Section Body Doc Link PMC2129137 Disease Relevance 0.36 Pain Relevance 0
Cytoseira canariensis has been marketed to increase muscle mass and decrease body fat by inhibiting myostatin, a growth and differentiation factor whose role is to inhibit (not promote) the growth of muscles.
Negative_regulation (inhibiting) of myostatin in fat
6) Confidence 0.06 Published 2006 Journal J Int Soc Sports Nutr Section Body Doc Link PMC2129138 Disease Relevance 0.06 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox